GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Standard BioTools Inc (NAS:LAB) » Definitions » Shiller PE Ratio
中文

Standard BioTools (Standard BioTools) Shiller PE Ratio

: (As of Today)
View and export this data going back to 2011. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


Standard BioTools Shiller PE Ratio Historical Data

The historical data trend for Standard BioTools's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Standard BioTools Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Standard BioTools Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Diagnostics & Research subindustry, Standard BioTools's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard BioTools Shiller PE Ratio Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Standard BioTools's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Standard BioTools's Shiller PE Ratio falls into.



Standard BioTools Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Standard BioTools's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Standard BioTools's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.25/129.4194*129.4194
=-0.250

Current CPI (Dec. 2023) = 129.4194.

Standard BioTools Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.570 99.695 -0.740
201406 -0.450 100.560 -0.579
201409 -0.490 100.428 -0.631
201412 -0.390 99.070 -0.509
201503 -0.560 99.621 -0.728
201506 -0.530 100.684 -0.681
201509 -0.320 100.392 -0.413
201512 -0.450 99.792 -0.584
201603 -0.690 100.470 -0.889
201606 -0.640 101.688 -0.815
201609 -0.680 101.861 -0.864
201612 -0.610 101.863 -0.775
201703 -0.590 102.862 -0.742
201706 -0.580 103.349 -0.726
201709 -0.460 104.136 -0.572
201712 -0.270 104.011 -0.336
201803 -0.340 105.290 -0.418
201806 -0.420 106.317 -0.511
201809 -0.380 106.507 -0.462
201812 -0.360 105.998 -0.440
201903 -0.440 107.251 -0.531
201906 -0.200 108.070 -0.240
201909 -0.190 108.329 -0.227
201912 -0.182 108.420 -0.217
202003 -0.230 108.902 -0.273
202006 -0.180 108.767 -0.214
202009 -0.080 109.815 -0.094
202012 -0.240 109.897 -0.283
202103 -0.250 111.754 -0.290
202106 -0.230 114.631 -0.260
202109 -0.180 115.734 -0.201
202112 -0.120 117.630 -0.132
202203 -0.990 121.301 -1.056
202206 -0.820 125.017 -0.849
202209 -0.370 125.227 -0.382
202212 -0.260 125.222 -0.269
202303 -0.210 127.348 -0.213
202306 -0.220 128.729 -0.221
202309 -0.270 129.860 -0.269
202312 -0.250 129.419 -0.250

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Standard BioTools  (NAS:LAB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Standard BioTools Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Standard BioTools's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Standard BioTools (Standard BioTools) Business Description

Traded in Other Exchanges
Address
2 Tower Place, Suite 2000, South San Francisco, CA, USA, 94080
Standard BioTools Inc manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. The company's segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
Executives
Martin D Madaus director 290 CONCORD ROAD, BILLERICA MA 01821
Jeffrey G. Black officer: SVP & Chief Financial Officer 4955 DIRECTORS PLACE, SAN DIEGO CA 92121
Eli Casdin director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Partners Master Fund, L.p. director, 10 percent owner WALKER HOUSE, 87 MARY STREET, GEORGE TOWN E9 KY1-9001
Casdin Partners Fo1-msv, Lp director C/O CASDIN PARTNERS GP, LLC, 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii Gp, Llc director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Partners Gp, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 1140, NEW YORK NY 10019
Casdin Capital, Llc director, 10 percent owner 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Casdin Private Growth Equity Fund Ii, L.p. director 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK NY 10019
Fenel M Eloi director C/O INTERLEUKIN GENETICS INC, 135 BEAVER STREET, WALTHAM MA 02452
Caligan Partners Lp 10 percent owner 515 MADISON AVENUE, 8TH FLOOR, NEW YORK NY 10022
Frank Witney director 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Jeremy Steven Davis officer: SVP Chief Commercial Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Hanjoon Alex Kim officer: Chief Operating Officer C/O FLUIDIGM CORPORATION, 2 TOWER PLACE, SUITE 2000, SOUTH SAN FRANCISCO CA 94080
Michael Egholm director, officer: President & CEO 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110